MAPK3 and glioblastoma: Next, we treated GBM cells with SCH772984, an inhibitor of ERK1/2 signaling, and found it blocked Rab32-induced mitochondrial fission and suppressed Drp1 phosphorylation at Ser616 (Fig. 6E, F and S6C).